Novartis wins Gilenya reprieve as judge blocks generics, for now

91

Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the Swiss drugmaker’s top-selling multiple sclerosis medicine Gilenya in the United States, at least until a patent dispute is resolved.

http://feeds.reuters.com/~r/reuters/healthNews/~3/iPFXY-YyONQ/novartis-wins-gilenya-reprieve-as-judge-blocks-generics-for-now-idUSKCN1TQ1EO

- Advertisement -